Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Milestone Pharmaceuticals Inc. MIST NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • CA • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.00
+263.6%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Milestone Pharmaceuticals Inc. (MIST), dont 35 achats et 12 ventes. Le total des achats d'initiés s'élève à $5.4M et le total des ventes d'initiés à $958.19K.

Les initiés notables ayant une activité récente comprennent Sandoval David I., Oliveto Joseph, Muller Lorenz. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — MIST

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-03-17 Sandoval David I. Gc & Chief Compliance Officer Inconnu 400,000 $1.96 $784K -
2026-02-02 Oliveto Joseph President and CEO Attribution de RSU 453,000 - - 453,000
2026-02-02 Muller Lorenz Chief Commercial Officer Attribution de RSU 136,000 - - 136,000
2026-02-02 Hasija Amit CFO & EVP of Corp. Development Attribution de RSU 136,000 - - 136,000
2026-02-02 Bharucha David Chief Medical Officer Attribution de RSU 136,000 - - 136,000
2026-02-02 Nelson Jeffrey Edward Chief Operating Officer Attribution de RSU 136,000 - - 136,000
2026-02-02 Oliveto Joseph President and CEO Attribution de RSU 679,000 $1.96 $1.33M 679,000
2026-02-02 Muller Lorenz Chief Commercial Officer Attribution de RSU 204,000 $1.96 $399.84K 204,000
2026-02-02 Hasija Amit CFO & EVP of Corp. Development Attribution de RSU 204,000 $1.96 $399.84K 204,000
2026-02-02 Bharucha David Chief Medical Officer Attribution de RSU 204,000 $1.96 $399.84K 204,000
2026-02-02 Nelson Jeffrey Edward Chief Operating Officer Attribution de RSU 204,000 $1.96 $399.84K 204,000
2026-01-26 Oliveto Joseph President and CEO Exercice d'Options (Vente) 66,600 - - 199,800
2026-01-26 Muller Lorenz Chief Commercial Officer Exercice d'Options (Vente) 20,100 - - 60,300
2026-01-26 Hasija Amit CFO & EVP of Corp. Development Exercice d'Options (Vente) 20,100 - - 60,300
2026-01-26 Bharucha David Chief Medical Officer Exercice d'Options (Vente) 20,100 - - 60,300
2026-01-26 Nelson Jeffrey Edward Chief Operating Officer Vente Informative 12,245 $1.93 $23.63K 49,848
2026-01-08 Oliveto Joseph President and CEO Vente Informative 43,000 $2.25 $96.75K 303,721
2026-01-07 Oliveto Joseph President and CEO Vente Informative 500 $2.25 $1.13K 346,721
2025-12-15 Oliveto Joseph President and CEO Vente Informative 133,054 $2.32 $308.69K 450,667
2025-12-15 Muller Lorenz Chief Commercial Officer Vente Informative 53,566 $2.32 $124.27K 196,486
2025-12-15 Hasija Amit CFO & EVP of Corp. Development Vente Informative 58,007 $2.32 $134.58K 91,993
2025-12-15 Bharucha David Chief Medical Officer Vente Informative 58,007 $2.32 $134.58K 105,326
2025-12-15 Nelson Jeffrey Edward Chief Operating Officer Vente Informative 58,007 $2.32 $134.58K 41,993
2025-12-12 Oliveto Joseph President and CEO Attribution de RSU 280,000 $1.74 $487.2K 280,000
2025-12-12 Muller Lorenz Chief Commercial Officer Attribution de RSU 100,000 $1.74 $174K 100,000
2025-12-12 Hasija Amit CFO & EVP of Corp. Development Attribution de RSU 100,000 $1.74 $174K 100,000
2025-12-12 Bharucha David Chief Medical Officer Attribution de RSU 100,000 $1.74 $174K 100,000
2025-12-12 Nelson Jeffrey Edward Chief Operating Officer Attribution de RSU 100,000 $1.74 $174K 100,000
2025-12-09 Muller Lorenz Chief Commercial Officer Don (Donné) 25,000 - - 150,052
2025-07-11 Papa Joseph C Director Attribution de RSU 100,000 $1.88 $187.5K 100,000
2025-07-11 Oliveto Joseph President and CEO Attribution de RSU 66,666 $1.88 $125K 66,666
2025-07-11 Wills Robert James Director Attribution de RSU 50,000 $1.50 $75K 50,000
2025-07-11 Muller Lorenz Chief Commercial Officer Attribution de RSU 66,666 $1.50 $100K 66,666
2025-07-11 Liebert Debra K. Director Attribution de RSU 16,666 $1.50 $25K 16,793
2025-07-11 Hasija Amit CFO & EVP of Corp. Development Attribution de RSU 50,000 $1.50 $75K 50,000
2025-07-11 Bharucha David Chief Medical Officer Attribution de RSU 53,333 $1.88 $100K 53,333
2025-06-10 Papa Joseph C Director Attribution de RSU 40,000 $1.75 $70K 40,000
2025-06-10 Giles Lisa M. Director Attribution de RSU 40,000 $1.75 $70K 40,000
2025-06-10 Tomsicek Michael John Director Attribution de RSU 40,000 $1.75 $70K 40,000
2025-06-10 Fischer Seth H. Z. Director Attribution de RSU 40,000 $1.75 $70K 40,000
2025-06-10 Saik Andrew Director Attribution de RSU 40,000 $1.75 $70K 40,000
2025-06-10 Wills Robert James Director Attribution de RSU 40,000 $1.75 $70K 40,000
2025-06-10 Duty Stuart Director Attribution de RSU 40,000 $1.75 $70K 40,000
2025-01-27 Oliveto Joseph President and CEO Attribution de RSU 266,400 - - 266,400
2025-01-27 Muller Lorenz Chief Commercial Officer Attribution de RSU 80,400 - - 80,400
2025-01-27 Hasija Amit CFO & EVP of Corp. Development Attribution de RSU 80,400 - - 80,400
2025-01-27 Bharucha David Chief Medical Officer Attribution de RSU 80,400 - - 80,400
2025-01-27 Nelson Jeffrey Edward Chief Operating Officer Attribution de RSU 80,400 - - 80,400
2024-09-03 Papa Joseph C Officer Inconnu - - - -
2024-09-03 Papa Joseph C Director Attribution de RSU 80,000 $1.39 $111.2K 80,000
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message